Oxford Asset Management’s Syndax Pharmaceuticals SNDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-102,631
| Closed | -$901K | – | 1141 |
|
|
2019
Q4 | $901K | Sell |
102,631
-5,945
| -5% | -$52.2K | 0.03% | 927 |
|
|
2019
Q3 | $811K | Buy |
108,576
+50,191
| +86% | +$375K | 0.02% | 1038 |
|
|
2019
Q2 | $544K | Sell |
58,385
-78,038
| -57% | -$727K | 0.01% | 1241 |
|
|
2019
Q1 | $716K | Buy |
136,423
+45,084
| +49% | +$237K | 0.02% | 1076 |
|
|
2018
Q4 | $406K | Buy |
+91,339
| New | +$406K | 0.01% | 1277 |
|
|
2018
Q3 | – | Sell |
-50,332
| Closed | -$349K | – | 1901 |
|
|
2018
Q2 | $349K | Sell |
50,332
-72,235
| -59% | -$501K | 0.01% | 1452 |
|
|
2018
Q1 | $1.74M | Sell |
122,567
-12,566
| -9% | -$179K | 0.04% | 648 |
|
|
2017
Q4 | $1.17M | Buy |
135,133
+86,691
| +179% | +$752K | 0.03% | 854 |
|
|
2017
Q3 | $574K | Buy |
48,442
+20,753
| +75% | +$246K | 0.01% | 1149 |
|
|
2017
Q2 | $387K | Buy |
+27,689
| New | +$387K | 0.01% | 1178 |
|